...
首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >Optimization and characterization of injectable chitosan-iodixanol-based hydrogels for the embolization of blood vessels
【24h】

Optimization and characterization of injectable chitosan-iodixanol-based hydrogels for the embolization of blood vessels

机译:用于血管栓塞的可注射壳聚糖-碘克沙醇基水凝胶的优化和表征

获取原文
获取原文并翻译 | 示例
           

摘要

Chitosan-thermosensitive hydrogels present interesting features for the embolization of blood vessels, but need to be better characterized and optimized. Chitosan polymer (degree of deacetylation (DDA) of 94%) was purified and combined with Visipaque (VIS), a nonionic isotonic contrast agent composed of iodixanol. A beta-glycerolphosphate (beta GP) solution was then added to induce gelation at body temperature. The gelation process was monitored by rheometry, measuring the evolution of the sample storage (G') and loss (G '') moduli as a function of VIS and beta GP concentration. Adding VIS significantly slowed down gelation kinetics, but a 12% and higher beta GP concentration provided a radiopaque solution, which at 37 degrees C, gels immediately. A custom-made in vitro embolization bench test was developed to assess the gel's occlusive properties, and its injectability through a small diameter catheter was verified. Results show that the short-term occlusive properties of the gel were insufficient when using a beta GP concentration of 12% w/v (about 0.4M), but that increasing the beta GP to 20% (0.6M) allowed an acceleration of the gelation and the immediate blocking of flow above physiological pressure. The contrast agent was rapidly released in solution, such that it would not interfere with future followup imaging. In accordance with the literature data, the cytotoxicity of gel extracts increased with beta GP concentration and to a lesser extent with VIS concentration. Preliminary in vivo testing showed easy injection by catheter and good visibility under fluoroscopy. These results suggest that radiopaque CH/beta GP20%/VIS hydrogels present significant potential as embolizing agents for blood vessels and aneurysms. (C) 2015 Wiley Periodicals, Inc.
机译:壳聚糖热敏水凝胶为血管栓塞提供了有趣的功能,但需要更好地表征和优化。纯化壳聚糖聚合物(脱乙酰度(DDA)为94%),并与Visipaque(VIS)(一种由碘克沙醇组成的非离子等渗造影剂)混合。然后添加β-甘油磷酸酯(βGP)溶液以在体温下诱导胶凝。通过流变法监测凝胶化过程,测量样品储藏模量(G')和模量损失(G'')随VIS和βGP浓度的变化。添加VIS显着减慢了凝胶动力学,但是12%或更高的βGP浓度提供了不透射线的溶液,该溶液在37摄氏度时立即胶凝。开发了一种定制的体外栓塞试验,以评估凝胶的闭塞性,并验证了其通过小直径导管的可注射性。结果表明,当使用浓度为12%w / v(约0.4M)的βGP时,凝胶的短期封闭特性不足,但是将βGP增加到20%(0.6M)可以加速凝胶的生长。胶凝并在生理压力以上立即阻断血流。造影剂在溶液中迅速释放,因此不会干扰以后的随访成像。根据文献数据,凝胶提取物的细胞毒性随着βGP浓度的增加而增加,而随着VIS浓度的增加而降低。初步的体内测试显示易于通过导管注射并且在荧光检查下可见度良好。这些结果表明,不透射线的CH /βGP20%/ VIS水凝胶具有作为血管和动脉瘤栓塞剂的巨大潜力。 (C)2015威利期刊公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号